Biotherapeutics Discovery Co-op

Company Overview

Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.

Position Overview

Beam is seeking a highly motivated co-op student to join the Biotherapeutics Discovery Team, from January through June 2027. The individual will be responsible for screening, characterizing, and optimizing therapeutic antibodies using cell biology, molecular biology, and biochemistry techniques to support biotherapeutic drug discovery programs at Beam. The position will play a key role in advancing new programs from discovery toward the clinic in a highly collaborative and fast-paced environment.

Responsibilities

Screen and characterize antibody and VHH candidates using affinity, biophysical, and developability assays including Octet, ELISA, SEC, thermal stability analysis. Establish and perform functional cell-based assays utilizing mammalian cell culture. Small/large scale protein production including transfection, purification and QC. Maintain detailed documentation of experiments in the ELN system. Collaborate and communicate effectively across a multidisciplinary team.

Qualifications

Pursuing a BS or MS in biological sciences or a related field (Bioengineering, B